Evaluation of a biosimilar recombinant alpha epoetin in the management of anemia in hemodialysis patients.

about

Comparative efficacy and safety in ESA biosimilars vs. originators in adults with chronic kidney disease: a systematic review and meta-analysis.

P2860

Q38711130-D15A352D-12A8-4BD4-9FFE-CB315181FB9E

P2860

Evaluation of a biosimilar recombinant alpha epoetin in the management of anemia in hemodialysis patients.

Item

http://www.wikidata.org/entity/Q36162041

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Evaluation of a biosimilar rec ...... emia in hemodialysis patients.

@ast

Evaluation of a biosimilar rec ...... emia in hemodialysis patients.

@en

type

Item

label

Evaluation of a biosimilar rec ...... emia in hemodialysis patients.

@ast

Evaluation of a biosimilar rec ...... emia in hemodialysis patients.

@en

prefLabel

Evaluation of a biosimilar rec ...... emia in hemodialysis patients.

@ast

Evaluation of a biosimilar rec ...... emia in hemodialysis patients.

@en

P1476

Evaluation of a biosimilar rec ...... emia in hemodialysis patients.

@en

P2093

Amirhossein Sahebkar

http://www.w3.org/2001/XMLSchema#string

Arash Hassanzadeh

http://www.w3.org/2001/XMLSchema#string

Eghlim Nemati

http://www.w3.org/2001/XMLSchema#string

Eisa T Marzony

http://www.w3.org/2001/XMLSchema#string

Fatemeh Beiraghdar

http://www.w3.org/2001/XMLSchema#string

Hamid T Khosroshahi

http://www.w3.org/2001/XMLSchema#string

Javid Safa

http://www.w3.org/2001/XMLSchema#string

Sadroddin R Hashemi

http://www.w3.org/2001/XMLSchema#string

Sima A Azar

http://www.w3.org/2001/XMLSchema#string

Yunes Panahi

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of anaemia on cardiovascular status.

The cardiovascular effects of erythropoietin.

Anemia in chronic kidney disease: causes, diagnosis, treatment.

Androgens and erythropoiesis: past and present.

Erythropoiesis stimulating agents and anaemia of end-stage renal disease.

Investigation of the efficacy of a biogeneric recombinant human erythropoietin alfa in the management of renal anemia in patients on hemodialysis: a multi-center clinical trial.

Efficacy of erythropoietin administration in the treatment of anemia immediately after renal transplantation.

Erythropoietin safety and efficacy in chronic allograft nephropathy.

Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Investigation of the efficacy of a biogeneric recombinant human erythropoietin alfa in the correction of post-transplantation anemia: a randomized comparative trial with Eprex.

P304

544-548

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JSPS.2015.02.007

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272946404

http://www.w3.org/2001/XMLSchema#string

P698

26594121

http://www.w3.org/2001/XMLSchema#string

P932

4605909

http://www.w3.org/2001/XMLSchema#string

Evaluation of a biosimilar recombinant alpha epoetin in the management of anemia in hemodialysis patients.

about

P2860

P2860

Evaluation of a biosimilar recombinant alpha epoetin in the management of anemia in hemodialysis patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932